Company / FCF Margin
Outlook Therapeutics, Inc. FCF Margin History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-401.8%
FY2020
5-year range
-1563.3% / -401.8%
FY2016-FY2020
Trend
+65.4%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 5 years, ranging from -1563.3% in FY2017 to -401.8% in FY2020.
Based on SEC 10-K filings.
-401.8% in FY2020 with a 3-year CAGR of +1161.6%.
Improved from -414.5% to -401.8% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +1161.6pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2020, fcf margin increased 65.4% year-over-year.
- Lowest fcf margin in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2020 | -401.8% | +65.4% |
| FY2019 | -1160.2% | -179.9% |
| FY2018 | -414.5% | +73.5% |
| FY2017 | -1563.3% | -124.9% |
| FY2016 | -695.1% | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026